HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing (Health)

Set Alert for Marketing {Health}

Product Launches

Set Alert for Launches {Health}

Latest From Health & Launches

Opill Launch Delivers For Perrigo While Growing Pains Slow Overall First-Quarter Results

Perrigo spares little about Opill’s launch, advertising and outlook in Q1 earnings briefing, but management also makes clear it’s a large firm and some other segments of its global consumer health products business are holding back overall results.

Sales & Earnings Women's Health

Bausch + Lomb’s Prescription For Consumer Health Sales Growth Includes ‘Benefit’ From Rx Drugs

Blink NutriTears supplement containing lutein/zeaxanthin, curcumin and vitamin D3 coming in 2024 is example of a cross-segment sales benefit B+L sees in dry eye product category. Consumer eye care and vision health product sales are key drivers for 18% Q1 net sales growth to $1.1bn.

Consumer Sales & Earnings

OTC Marketing Awards 2024 Now Open For Entries

Returning for its 29th year, the Oscars of the OTC industry is now inviting entries from UK consumer health players across 12 categories.

Innovation Ad Campaigns
See All

Advertising Campaigns

Set Alert for Ad Campaigns {Health}

Latest From Health & Ad Campaigns

OTC Marketing Awards 2024 Now Open For Entries

Returning for its 29th year, the Oscars of the OTC industry is now inviting entries from UK consumer health players across 12 categories.

Innovation Ad Campaigns

Federal Judge Knows ‘Clear’ When He Reads It

The regulation “is clear, as is the Court’s order” rejecting CRN’s motion for preliminary injunction against imposition of the regulation, says US district Judge Andrew Carter in order denying the trade group’s request for clarification of New York regulation.

Litigation Dietary Supplements

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief. 

United Kingdom Health
See All

Advertising Enforcement

Set Alert for Ad Complaints {Health}

Latest From Health & Ad Complaints

EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine

Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive. 

Europe Health

Take Care With ‘Health Lite’ Claims

Some advertisers try to avoid scrutiny of regulators and the National Advertising Division when making health-related claims by making a claim “softer.” Annie Ugurlayan, NAD’s assistant director, offers advice on assuring substantiation and a health claim match.

Ad Complaints Dietary Supplements

ASA Files: How Not To Advertise A Digital Health App In The UK

ADHD-management software Happyo falls foul of UK advertising rules in a recent ASA case. The lesson: if in the UK the intended use of a digital health app is the diagnosis of a serious medical condition, supervision by a healthcare professional such as a doctor is likely to be necessary, in which case advertising to the public would also be prohibited.

United Kingdom Health
See All
UsernamePublicRestriction

Register